(CCL) Carnival - Ratings and Ratios
Ocean Cruises, River Cruises, Destination Resorts, Rail Tours
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 42.4% |
| Value at Risk 5%th | 63.9% |
| Relative Tail Risk | -8.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | -2.82 |
| CAGR/Max DD | 1.19 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.446 |
| Beta | 1.735 |
| Beta Downside | 1.844 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.85% |
| Mean DD | 13.98% |
| Median DD | 13.13% |
Description: CCL Carnival December 03, 2025
Carnival Corporation & plc (NYSE: CCL) is the world’s largest cruise operator, delivering leisure travel across North America, Europe, Australia and global itineraries. The business is organized into four segments-NAA Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour & Other-and markets its voyages through a mix of travel agents, online channels and onboard consultants under ten well-known brands, including Carnival Cruise Line, Princess Cruises, Holland America, and Cunard.
Key operating metrics that investors watch include a 2023 average occupancy of roughly 92 % and a cash-flow conversion rate of about 1.1 ×, indicating that earnings are largely supported by operating cash. The segment’s exposure to fuel price volatility remains material; a 10 % rise in bunker fuel can erode EBITDA by an estimated 3-4 %, while the ongoing rebound in discretionary consumer spending and stronger U.S. consumer confidence have been primary drivers of the recent demand surge. Additionally, Carnival’s leverage has improved, with net debt/EBITDA falling to ~2.6 × in Q3 2024, down from a peak of 4.5 × during the pandemic shutdown.
For a deeper quantitative view, you may want to explore ValueRay’s analyst dashboard for the latest model-based forecasts.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.76b TTM) > 0 and > 6% of Revenue (6% = 1.60b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 3.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -33.33% (prev -32.93%; Δ -0.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 5.61b > Net Income 2.76b (YES >=105%, WARN >=100%) |
| Net Debt (26.07b) to EBITDA (6.89b) ratio: 3.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.40b) change vs 12m ago 0.29% (target <= -2.0% for YES) |
| Gross Margin 37.37% (prev 37.50%; Δ -0.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.85% (prev 51.01%; Δ 1.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.08 (EBITDA TTM 6.89b / Interest Expense TTM 1.33b) >= 6 (WARN >= 3) |
Altman Z'' -0.19
| (A) -0.17 = (Total Current Assets 4.22b - Total Current Liabilities 13.09b) / Total Assets 51.69b |
| (B) 0.09 = Retained Earnings (Balance) 4.82b / Total Assets 51.69b |
| (C) 0.08 = EBIT TTM 4.10b / Avg Total Assets 50.37b |
| (D) 0.09 = Book Value of Equity 3.38b / Total Liabilities 39.40b |
| Total Rating: -0.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.01
| 1. Piotroski 4.50pt |
| 2. FCF Yield 4.39% |
| 3. FCF Margin 10.95% |
| 4. Debt/Equity 2.28 |
| 5. Debt/Ebitda 3.78 |
| 6. ROIC - WACC (= 3.67)% |
| 7. RoE 25.45% |
| 8. Rev. Trend 79.44% |
| 9. EPS Trend 80.47% |
What is the price of CCL shares?
Over the past week, the price has changed by -2.27%, over one month by +17.78%, over three months by +5.64% and over the past year by +22.55%.
Is CCL a buy, sell or hold?
- Strong Buy: 17
- Buy: 5
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CCL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.6 | 19.9% |
| Analysts Target Price | 36.6 | 19.9% |
| ValueRay Target Price | 33.4 | 9.4% |
CCL Fundamental Data Overview December 28, 2025
P/E Trailing = 15.198
P/E Forward = 12.4533
P/S = 1.513
P/B = 3.3377
P/EG = 1.41
Beta = 2.536
Revenue TTM = 26.62b USD
EBIT TTM = 4.10b USD
EBITDA TTM = 6.89b USD
Long Term Debt = 25.06b USD (from longTermDebt, two quarters ago)
Short Term Debt = 2.78b USD (from shortTermDebt, last quarter)
Debt = 27.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 26.07b USD (from netDebt column, last quarter)
Enterprise Value = 66.34b USD (40.28b + Debt 27.99b - CCE 1.93b)
Interest Coverage Ratio = 3.08 (Ebit TTM 4.10b / Interest Expense TTM 1.33b)
FCF Yield = 4.39% (FCF TTM 2.91b / Enterprise Value 66.34b)
FCF Margin = 10.95% (FCF TTM 2.91b / Revenue TTM 26.62b)
Net Margin = 10.37% (Net Income TTM 2.76b / Revenue TTM 26.62b)
Gross Margin = 37.37% ((Revenue TTM 26.62b - Cost of Revenue TTM 16.67b) / Revenue TTM)
Gross Margin QoQ = 26.75% (prev 46.22%)
Tobins Q-Ratio = 1.28 (Enterprise Value 66.34b / Total Assets 51.69b)
Interest Expense / Debt = 1.13% (Interest Expense 315.0m / Debt 27.99b)
Taxrate = -4.46% (negative due to tax credits) (-18.0m / 404.0m)
NOPAT = 4.28b (EBIT 4.10b * (1 - -4.46%)) [negative tax rate / tax credits]
Current Ratio = 0.32 (Total Current Assets 4.22b / Total Current Liabilities 13.09b)
Debt / Equity = 2.28 (Debt 27.99b / totalStockholderEquity, last quarter 12.28b)
Debt / EBITDA = 3.78 (Net Debt 26.07b / EBITDA 6.89b)
Debt / FCF = 8.94 (Net Debt 26.07b / FCF TTM 2.91b)
Total Stockholder Equity = 10.85b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.34% (Net Income 2.76b / Total Assets 51.69b)
RoE = 25.45% (Net Income TTM 2.76b / Total Stockholder Equity 10.85b)
RoCE = 11.41% (EBIT 4.10b / Capital Employed (Equity 10.85b + L.T.Debt 25.06b))
RoIC = 11.48% (NOPAT 4.28b / Invested Capital 37.29b)
WACC = 7.80% (E(40.28b)/V(68.27b) * Re(12.41%) + D(27.99b)/V(68.27b) * Rd(1.13%) * (1-Tc(-0.04)))
Discount Rate = 12.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.85%
[DCF Debug] Terminal Value 53.59% ; FCFE base≈2.24b ; Y1≈1.47b ; Y5≈672.2m
Fair Price DCF = 6.55 (DCF Value 7.65b / Shares Outstanding 1.17b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 80.47 | EPS CAGR: 176.7% | SUE: 2.78 | # QB: 5
Revenue Correlation: 79.44 | Revenue CAGR: 43.75% | SUE: -0.56 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.18 | Chg30d=-0.008 | Revisions Net=-1 | Analysts=16
EPS current Year (2026-11-30): EPS=2.50 | Chg30d=+0.066 | Revisions Net=+2 | Growth EPS=+10.9% | Growth Revenue=+4.4%
EPS next Year (2027-11-30): EPS=2.81 | Chg30d=+0.033 | Revisions Net=+2 | Growth EPS=+12.6% | Growth Revenue=+3.9%
Additional Sources for CCL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle